Show simple item record

Monitoring tyrosinaemia type I: Blood spot test for nitisinone (NTBC).

dc.contributor.authorDemirkol, Mubeccel
dc.contributor.authorGokcay, Gülden Fatma
dc.contributor.authorSander, Stefanie
dc.contributor.authorPeter, Michael
dc.contributor.authorDas, Anibh M.
dc.contributor.authorOzer, Isil
dc.contributor.authorSander, Johannes
dc.contributor.authorJanzen, Nils
dc.contributor.authorTerhardt, Michael
dc.date.accessioned2021-03-05T10:35:19Z
dc.date.available2021-03-05T10:35:19Z
dc.identifier.citationSander J., Janzen N., Terhardt M., Sander S., Gokcay G. F. , Demirkol M., Ozer I., Peter M., Das A. M. , "Monitoring tyrosinaemia type I: Blood spot test for nitisinone (NTBC).", Clinica chimica acta; international journal of clinical chemistry, cilt.412, ss.134-8, 2011
dc.identifier.issn0009-8981
dc.identifier.othervv_1032021
dc.identifier.otherav_a3e31367-8878-437b-accb-cfb3acba694c
dc.identifier.urihttp://hdl.handle.net/20.500.12627/109691
dc.identifier.urihttps://doi.org/10.1016/j.cca.2010.09.027
dc.description.abstractBackground: Quantification of nitisinone, 2-(nitro-4-trifluoromethylbenzoyl)1,3-cyclohexanedione (NTBC) has been repeatedly described. Nevertheless monitoring of NTBC has not yet become part of routine therapy surveillance in tyrosinaemia type I (OMIM 276700).
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectSağlık Bilimleri
dc.subjectTIBBİ LABORATUVAR TEKNOLOJİSİ
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.titleMonitoring tyrosinaemia type I: Blood spot test for nitisinone (NTBC).
dc.typeMakale
dc.relation.journalClinica chimica acta; international journal of clinical chemistry
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume412
dc.identifier.startpage134
dc.identifier.endpage8
dc.contributor.firstauthorID198878


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record